article thumbnail

Outcomes of Guidelines from Health Technology Assessment Organizations: A Systematic Mixed Studies Review [Systematic review, meta-analysis, or scoping review]

Annals of Family Medicine

Context: Health Technology Assessment (HTA) organizations determine the value of health technologies such as medical devices, lab tests, or medications. positive, neutral, and negative impact) are presented for 17 types of outcomes. Twenty-nine types of outcomes are qualitatively documented.

article thumbnail

You don’t need labs to medically clear a psych patient

PEMBlog

However, the vast majority of pediatric patients with psychiatric complaints do not present with undifferentiated acute psychosis; rather, they are seen for behavioral concerns or suicidal ideation. When should the emergency physician obtain lab tests to medically clear such patients?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Reasoning Corner: Illness Script

The Clinical Problem Solvers

In the reasoning process, we use illness scripts to compare and contrast a patient’s clinical presentation (i.e., So the illness script we developed as a first-year medical student will evolve over time. lab tests, imaging, and/or pathology). shortness of breath is present in heart failure and pneumonia).

Illness 52
article thumbnail

Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy

GeriPal

Today we are coming back for more (or less given the content), talking about the following articles with their lead authors: First up, we talk with Ariel Green about her article in JAMA Network on preferred phrases a clinician may use to explain why they should reduce or stop the medication. That’s huge! Welcome, Ariel. Ariel: Thanks.

article thumbnail

It’s My Party and I’ll Cry if I Want to: A Bittersweet Happy 30th Birthday to LDTs

FDA Law Blog

These products are subject to the same regulatory requirements as any unapproved medical device”). Of course, FDA’s August 3, 1992 statement that it could regulate LDTs came long after laboratories began offering diagnostic tests. See AdvaMed Welcomes Senate Committee Passage of MDUFA V Legislation (June 15, 2022).

article thumbnail

Under Pressure: Hypertensive Emergencies in the Pediatric Emergency Department

PEMBlog

In the case presented, the patients blood pressure was significantly elevated, and she exhibited symptoms indicative of end-organ involvement, including altered mental status, headache, and nausea. Additional lab testing can be completed to account for the broader differential diagnoses. Labetalol dosing: 0.2-1

article thumbnail

How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin

GeriPal

We now have biomarkers that can reasonably approximate the degree of amyloid build-up in the brain with a simple blood test. We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. I just had lab tests done. And I pretty much present it as.